Related Experiment Video
Updated: Jun 2, 2026
05:44
Rodent Inferior Vena Cava Venoplasty Balloon Model
Published on: May 24, 2024
[Risk factors for recurrent venous thromboembolism]
J Rosencher1, T Mirault, I Martinez
1Unité Inserm U765, université Paris Descartes, faculté de médecine, 75508 Paris cedex, France.
Revue Des Maladies Respiratoires
|May 10, 2011
Summary
Predicting recurrent venous thromboembolism (VTE) is crucial for balancing anticoagulation benefits against bleeding risks. Clinical factors and d-dimer levels aid in assessing individual recurrence probability.
Area of Science:
- Hematology
- Cardiovascular Medicine
- Clinical Risk Prediction
Context:
- Recurrent venous thromboembolism (VTE) poses a significant and potentially fatal health risk.
- Long-term antithrombotic therapy mitigates VTE recurrence but elevates bleeding complications, limiting its universal application.
- Accurate individual risk assessment is paramount for optimizing anticoagulation therapy decisions.
Purpose:
- To identify key predictors for recurrent VTE to inform clinical decision-making.
- To evaluate the utility of clinical risk factors and biomarkers in predicting VTE recurrence.
- To guide the risk-benefit assessment of long-term anticoagulation in VTE patients.
Summary:
- Identified clinical risk factors for recurrent VTE include unprovoked first episode, proximal location, male gender, residual venous thrombosis, cancer, and antiphospholipid syndrome.
- Post-anticoagulation d-dimer levels demonstrate good negative predictive value for VTE recurrence.
- Genetic factors and deficiencies in natural anticoagulant proteins show limited association with VTE recurrence.
Impact:
- Facilitates personalized VTE management by enabling better risk stratification.
- Informs the judicious use of long-term anticoagulation, potentially reducing bleeding events.
- Highlights areas for future research, including the development of novel antithrombotic agents.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:26Varicose Veins I: Introduction
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...